Cardlytics Announces Preliminary Fourth Quarter 2019 Financial Results
ATLANTA, Jan. 13, 2020 (GLOBE NEWSWIRE) — Cardlytics, Inc., (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant […]
Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma
HOUSTON, Jan. 13, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced that the U.S. […]
HTG Molecular Diagnostics Announces Preliminary 2019 Unaudited Financial Results
Preliminary full year 2019 unaudited revenue of $19.2 millionCash and cash equivalents of $33.0 million as of December 31, 2019TUCSON, […]
IMAC Expands Reach to Southwest Florida with Purchase of Established Practice in All Cash Transaction
BRENTWOOD, Tenn., Jan. 13, 2020 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and […]
Kiniksa Announces Pipeline Progress and Reiterates 2020 Clinical Data Readouts
– Enrollment target achieved for rilonacept Phase 3 trial in recurrent pericarditis; top-line data expected in 2H 2020 –– Enrollment […]
AzurRx BioPharma Announces Closing of $6.9 Million Private Placement
NEW YORK, Jan. 13, 2020 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in […]
MediWound Expands its Distribution Agreement with GENFA MEDICA SA to Market NexoBrid in Ukraine and the Baltic States
YAVNE, Israel, Jan. 13, 2020 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to […]
Pixelworks and OPPO Group Sign Multi-Year Collaboration Agreement
SAN JOSE, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) — Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing […]
Fate Therapeutics Announces Expansion of FT516 Clinical Investigation and Publication of Preclinical Data in the Journal Blood
FT516 IND Application Cleared by FDA for Advanced Solid Tumors in Combination with PDL1-, EGFR- and HER2-targeting Therapeutic AntibodiesPublished Preclinical […]
PetIQ, Inc. Enters Into Definitive Agreement to Acquire the Capstar® portfolio of products from Elanco
EAGLE, Idaho, Jan. 13, 2020 (GLOBE NEWSWIRE) — PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication […]
